ARTICLE SUMMARY:
Abbott is running an acute feasibility trial of its Aveir Conduction System Pacing (CSP) leadless pacemaker system, representing the first implantations of a leadless pacemaker into the heart’s left bundle branch area.
Abbott is pushing ahead with a promising new approach to leadless cardiac pacing that relies on the heart’s natural conduction system to more closely mimic the heart’s own rhythm.
